Use of Cadmium [🇷 for BE/BA]

posted by ElMaestro  – Denmark, 2011-01-20 18:53 (5225 d 11:39 ago) – Posting: # 6462
Views: 30,580

OK, here what I meant with my last posts and the gibberish code.

[image]

We have for instance 24 patients in a 2,2,3-BE trial, expected T/R being 1.0 and expected CV is 30%. This gives us a power of 0.87. Scaling preserves power. Thus should the variability be 50% and with preserved power we have 0.6983 as our lower acceptance range and 1.4320 as the upper. Wunderbar. This is the blue line, or shall we call it the EMA line.

I propose to check how the behavior is once the expected R/T diviates from 1.0 and being 0.95 (red), 0.90 (yellow) and 0.85 (green); these curves preserve the power within themselves but of course not between them. It was intended as a graphical illustration of the limitation of the EMA approximation when T/R differs from 1.0.

Note: We are now no longer so intimately connected with the original thread topic.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
125 visitors (0 registered, 125 guests [including 5 identified bots]).
Forum time: 07:33 CEST (Europe/Vienna)

If you shut your door to all errors
truth will be shut out.    Rabindranath Tagore

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5